Gene therapy offers an alternative approach to the treatment/cure of T1D, whereby an “artificial β cell” that is capable of synthesising insulin in response to the normal metabolic signals is genetically engineered from the patient’s own cells. Here, INS is linked to type 1 diabetes mellitus.